Replacing Animals: UK Roadmap Calls On Regulators To Get Involved
This article was originally published in SRA
Executive Summary
Regulators should be involved early in the development of 'non-animal technologies' (NATs)' to expedite their regulatory acceptance for testing the safety and efficacy of new pharmaceuticals, according to a roadmap by Innovate UK, the government agency that identifies, plans and invests in emerging technologies that have the potential to drive future economic growth1.